Cocaine esterase: Interactions with cocaine and immune responses in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 320, Issue 2, 2007, Pages 926-933

  Ko, Mei Chuan ^a   Bowen, Luvina D ^a   Narasimhan, Diwahar ^a   Berlin, Aaron A ^a   Lukacs, Nicholas W ^a   Sunahara, Roger K ^a   Cooper, Ziva D ^a   Woods, James H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLESTERASE; COCAINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG EFFICACY; IMMUNE RESPONSE; IMMUNOGENICITY; IN VIVO STUDY; LETHALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOXICITY;

ANIMALS; ANTIBODIES; CARBOXYLIC ESTER HYDROLASES; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; SEIZURES; TIME FACTORS;

EID: 33846439351     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.114223     Document Type: Article

References (36)

1. Alving CR, Koulchin V, Glenn GM, and Rao M (1995) Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides. Immunol Rev 145:5-31.
2. Bauman JL and DiDomenico RJ (2002) Cocaine-induced channelopathies: emerging evidence on the multiple mechanisms of sudden death. J Cardiovasc Pharmacol Ther 7:195-202.
3. Benowitz NL (1993) Clinical pharmacology and toxicology of cocaine. Pharmacol Toxicol 72:3-12.
4. Bresler MM, Rosser SJ, Basran A, and Bruce NC (2000) Gene cloning and nucleotide sequencing and properties of a cocaine esterase from Rhodococcus sp. strain MB1. Appl Environ Microbiol 66:904-908.
5. Carrera MRA, Trigo JM, Wirsching P, Roberts AJ, and Janda KD (2005) Evaluation of the anticocaine monoclonal antibody GNC92H2 as an immunotherapy for cocaine overdose. Pharmacol Biochem Behav 81:709-714.
6. Cooper ZD, Narasimhan D, Sunahara RK, Mierzejewski P, Jutkiewicz EM, Larsen NA, Wilson IA, Landry DW, and Woods JH (2006) Rapid and robust protection against cocaine-induced lethality in rats by the bacterial cocaine esterase. Mol Pharmacol 70:1885-1891.
7. Crumb WJ Jr and Clarkson CW (1990) Characterization of cocaine-induced block of cardiac sodium channels. Biophys J 57:589-599.
8. Daniels A, Ayala E, Chen W, Coop A, and Matsumoto RR (2006) N-[2-(m-methoxyphenyl) ethyl]-N-ethyl-2-(1-pyrrolidinyl) ethylamine (UMB 116) is a novel antagonist for cocaine-induced effects. Eur J Pharmacol 542:61-68.
9. Deng SA, de Prada P, and Landry DW (2002) Anticocaine catalytic antibodies. J Immunol Methods 269:299-310.
10. Dickerson TJ and Janda KD (2005) Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy. AAPS Journal 7:E579-586.
11. Dhuna A, Pascual-Leone A, Langendorf F, and Anderson D (1991) Epileptogenic properties of cocaine in humans. Neurotoxicology 12:621-626.
12. Gasior M, Ungard JT, and Witkin JM (2000) Chlormethiazole: effectiveness against toxic effects of cocaine in mice. J Pharmacol Exp Ther 295:153-161.
13. Harris JM and Chess RB (2003) Effect of pegylation on pharmaceuticals. Natl Rev Drug Discov 2:214-221.
14. Hoffman BJ, Mezey E, and Brownstein MJ (1991) Cloning of a serotonin transporter affected by antidepressants. Science (Wash DC) 254:579-580.
15. Kilty JE, Lorang D, and Amara SG (1991) Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science (Wash DC) 254:578-579.
16. Koetzner L, Deng S, Sumpter TL, Weisslitz M, Abner RT, Landry DW, and Woods JH (2001) Titer-dependent antagonism of cocaine following active immunization in rhesus monkeys. J Pharmacol Exp Ther 296:789-796.
17. Kramer LD, Locke GE, Ogunyemi A, and Nelson L (1990) Cocaine-related seizures in adults. Am J Drug Alcohol Abuse 16:307-317.
18. Larsen NA, Turner JM, Stevens J, Rosser SJ, Basran A, Lerner RA, Bruce NC, and Wilson IA (2002) Crystal structure of a bacterial cocaine esterase. Nat Struct Biol 9:17-21.
19. Lynch TJ, Mattes CE, Singh A, Bradley RM, Brady RO, and Dretchen KL (1997) Cocaine detoxification by human plasma butyrylcholinesterase. Toxicol Appl Pharmacol 145:363-371.
20. Mattes CE, Lynch TJ, Singh A, Bradley RM, Kellaris PA, Brady RO, and Dretchen KL (1997) Therapeutic use of butyrylcholinesterase for cocaine intoxication. Toxicol Appl Pharmacol 145:372-380.
21. + channels: cocaine vs. quaternary compounds. Biophys J 58:95-106.
22. National Institute on Drug Abuse (2004) Cocaine Abuse and Addiction. NIDA Research Report Series. NIH Publication No. 99-4342 (Rev. Nov. 2004).
23. O'Leary ME and Chahine M (2002) Cocaine binds to a common site on open and inactivated human heart (Na(v)1.5) sodium channels. J Physiol (Lond) 541:701-716.
24. Pacholczyk T, Blakely RD, and Amara SG (1991) Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter. Nature (Lond) 350:350-354.
25. Pan Y, Gao D, Yang W, Cho H, Yang G, Tai HH, and Zhan CG (2005) Computational redesign of human butyrylcholinesterase for anticocaine medication. Proc Natl Acad Sci USA 102:16656-16661.
26. Ramamoorthy S and Blakely RD (1999) Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science (Wash DC) 285:763-766.
27. Rogers CJ, Mee JM, Kaufmann GF, Dickerson TJ, and Janda KD (2005) Toward cocaine esterase therapeutics. J Am Chem Soc 127:10016-10017.
28. Shu Q, Bir SH, Gill HS, Duan E, Xu Y, Hillard MA, and Rowe JB (2001) Antibody response in sheep following immunization with Streptococcus bovis in different adjuvants. Vet Res Commun 25:43-54.
29. Sofuoglu M and Kosten TR (2005) Novel approaches to the treatment of cocaine addiction. CNS Drugs 19:13-25.
30. Substance Abuse and Mental Health Services Administration (2005) Overview of Findings from the 2004 National Survey on Drug Use and Health. Office of Applied Studies, NSDUH Series H-27, DHHS Publication No. SMA 05-4061, Rockville, MD.
31. Substance Abuse and Mental Health Services Administration (2006) Drug Abuse Warning Network, 2004: National Estimates of Drug-Related Emergency Department Visits. Office of Applied Studies, DAWN Series D-28, DHHS Publication No. SMA 06-4143, Rockville, MD.
32. Turner JM, Larsen NA, Basran A, Barbas CF III, Bruce NC, Wilson IA, and Lerner RA (2002) Biochemical characterization and structural analysis of a highly proficient cocaine esterase. Biochemistry 41:12297-12307.
33. Vocci FJ, Acri J, and Elkashef A (2005) Medication development for addictive disorders: the state of the science. Am J Psychiatry 162:1432-1440.
34. Wilson LD and Shelat C (2003) Electrophysiologic and hemodynamic effects of sodium bicarbonate in a canine model of severe cocaine intoxication. J Toxicol Clin Toxicol 41:777-788.
35. Wright SN, Wang SY, Kallen RG, and Wang GK (1997) Differences in steady-state inactivation between Na channel isoforms affect local anesthetic binding affinity. Biophys J 73:779-788.
36. Zhang S, Rajamani S, Chen Y, Gong Q, Rong Y, Zhou Z, Ruoho A, and January CT (2001) Cocaine blocks HERG, but not KvLQT1+minK, potassium channels. Mol Pharmacol 59:1069-1076.